Evidence map›Paper›PMID 41926477›Full record

ArticleCerebrovascular diseases (Basel, Switzerland)2026

Hospital Socioeconomic Status and Acute Stroke Treatment in the United States.

Laura K Stein, Tam Tran, Jaan Nandwani, Benjamin H Oseroff, Mandip S Dhamoon

Abstract read
In one paragraph

Article in Cerebrovascular diseases (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laura K SteinDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA, laura.stein@mssm.edu.
Tam TranDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Jaan NandwaniDepartment of Medical Education, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Benjamin H OseroffDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Mandip S DhamoonDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSocial and structural determinants of health influence acute ischemic stroke (AIS) care, yet the effects of treating hospital characteristics are difficult to measure. We assessed the association between hospital socioeconomic status, measured by area deprivation index (ADI), and likelihood of treatment with revascularization therapy among Medicare AIS patients.

methodsA retrospective analysis of complete, de-identified Medicare fee-for-service data from January 1, 2016, to December 31, 2019. AIS admissions were identified by International Classification of Diseases, Tenth Revision, Clinical Modification Codes (163.x) in the primary position. Demographic characteristics, comorbidities, treatment characteristics, and outcomes were abstracted. Treating hospital socioeconomic status was measured by ADI (1-100), from lowest to highest deprivation. We performed unadjusted and adjusted logistic regression models testing the associations between hospital deprivation and treatment with intravenous thrombolysis and endovascular thrombectomy (ET), as well as outcomes, in 10-unit ADI increments.

resultsThere were 9,51,845 AIS admissions, and ADI was available for 78.6% (n = 7,48,605) of AIS admissions and 70.1% of treating hospitals (n = 3,563). Mean treating hospital ADI was 60.7 (SD: 26.9). Every 10-unit increase in ADI was associated with 8% lower odds of treatment with thrombolysis (OR: 0.92, 95% CI: 0.90-0.93, p < 0.0001) and 17% lower odds of treatment with ET (OR: 0.83, 95% CI: 0.77-0.90, p < 0.0001). Every 10-unit increase in ADI was associated with 1% lower odds of home discharge (OR: 0.99, 95% CI: 0.98-1.00, p = 0.0006) and 1% greater odds of 30-day mortality (OR: 1.01, 95% CI: 1.01-1.02, p < 0.0001), despite 3% lower odds of inpatient mortality (OR: 0.97, 95% CI: 0.96-0.99, p < 0.0001) and 4% greater odds of 30-day outpatient visit (OR: 1.04, 95% CI: 1.03-1.05, p < 0.0001).

conclusionAIS patients treated at hospitals of lower socioeconomic status are less likely to receive revascularization therapy and face poorer outcomes, though they have lower odds of inpatient mortality. These findings warrant further investigation in the face of increasing hospital consolidation and evolution of stroke systems of care.

Indexed as

Healthcare deliveryIschemic strokeThrombectomyThrombolytic therapy

Identifiers

PMID41926477
PMCPMC13262991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.